Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Remicade
1.2.3 Humira
1.2.4 Enbrel
1.2.5 Rituxan
1.2.6 Orencia
1.2.7 Actemra
1.2.8 Simponi
1.2.9 Cimzia
1.3 Market by Application
1.3.1 Global Arthritis Monoclonal Antibodies Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Arthritis Monoclonal Antibodies Market Perspective (2018-2033)
2.2 Arthritis Monoclonal Antibodies Growth Trends by Region
2.2.1 Global Arthritis Monoclonal Antibodies Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Arthritis Monoclonal Antibodies Historic Market Size by Region (2018-2023)
2.2.3 Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2024-2033)
2.3 Arthritis Monoclonal Antibodies Market Dynamics
2.3.1 Arthritis Monoclonal Antibodies Industry Trends
2.3.2 Arthritis Monoclonal Antibodies Market Drivers
2.3.3 Arthritis Monoclonal Antibodies Market Challenges
2.3.4 Arthritis Monoclonal Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue
3.1.1 Global Top Arthritis Monoclonal Antibodies Players by Revenue (2018-2023)
3.1.2 Global Arthritis Monoclonal Antibodies Revenue Market Share by Players (2018-2023)
3.2 Global Arthritis Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Arthritis Monoclonal Antibodies Revenue
3.4 Global Arthritis Monoclonal Antibodies Market Concentration Ratio
3.4.1 Global Arthritis Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Arthritis Monoclonal Antibodies Revenue in 2022
3.5 Arthritis Monoclonal Antibodies Key Players Head office and Area Served
3.6 Key Players Arthritis Monoclonal Antibodies Product Solution and Service
3.7 Date of Enter into Arthritis Monoclonal Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Arthritis Monoclonal Antibodies Breakdown Data by Type
4.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Type (2018-2023)
4.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2024-2033)
5 Arthritis Monoclonal Antibodies Breakdown Data by Application
5.1 Global Arthritis Monoclonal Antibodies Historic Market Size by Application (2018-2023)
5.2 Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Arthritis Monoclonal Antibodies Market Size (2018-2033)
6.2 North America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Arthritis Monoclonal Antibodies Market Size by Country (2018-2023)
6.4 North America Arthritis Monoclonal Antibodies Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Arthritis Monoclonal Antibodies Market Size (2018-2033)
7.2 Europe Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Arthritis Monoclonal Antibodies Market Size by Country (2018-2023)
7.4 Europe Arthritis Monoclonal Antibodies Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Arthritis Monoclonal Antibodies Market Size (2018-2033)
8.2 Asia-Pacific Arthritis Monoclonal Antibodies Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2018-2023)
8.4 Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Arthritis Monoclonal Antibodies Market Size (2018-2033)
9.2 Latin America Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2018-2023)
9.4 Latin America Arthritis Monoclonal Antibodies Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Arthritis Monoclonal Antibodies Market Size (2018-2033)
10.2 Middle East & Africa Arthritis Monoclonal Antibodies Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2018-2023)
10.4 Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Detail
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Arthritis Monoclonal Antibodies Introduction
11.1.4 AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.1.5 AbbVie Inc Recent Development
11.2 F. Hoffmann-La Roche Ltd
11.2.1 F. Hoffmann-La Roche Ltd Company Detail
11.2.2 F. Hoffmann-La Roche Ltd Business Overview
11.2.3 F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Introduction
11.2.4 F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Ltd Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Arthritis Monoclonal Antibodies Introduction
11.3.4 Novartis Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson(Janssen)
11.4.1 Johnson & Johnson(Janssen) Company Detail
11.4.2 Johnson & Johnson(Janssen) Business Overview
11.4.3 Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Introduction
11.4.4 Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.4.5 Johnson & Johnson(Janssen) Recent Development
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Detail
11.5.2 Pfizer Inc Business Overview
11.5.3 Pfizer Inc Arthritis Monoclonal Antibodies Introduction
11.5.4 Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.5.5 Pfizer Inc Recent Development
11.6 Mylan
11.6.1 Mylan Company Detail
11.6.2 Mylan Business Overview
11.6.3 Mylan Arthritis Monoclonal Antibodies Introduction
11.6.4 Mylan Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.6.5 Mylan Recent Development
11.7 Genentech
11.7.1 Genentech Company Detail
11.7.2 Genentech Business Overview
11.7.3 Genentech Arthritis Monoclonal Antibodies Introduction
11.7.4 Genentech Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.7.5 Genentech Recent Development
11.8 GSK
11.8.1 GSK Company Detail
11.8.2 GSK Business Overview
11.8.3 GSK Arthritis Monoclonal Antibodies Introduction
11.8.4 GSK Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.8.5 GSK Recent Development
11.9 AstraZeneca PLC
11.9.1 AstraZeneca PLC Company Detail
11.9.2 AstraZeneca PLC Business Overview
11.9.3 AstraZeneca PLC Arthritis Monoclonal Antibodies Introduction
11.9.4 AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2018-2023)
11.9.5 AstraZeneca PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Arthritis Monoclonal Antibodies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Remicade
Table 3. Key Players of Humira
Table 4. Key Players of Enbrel
Table 5. Key Players of Rituxan
Table 6. Key Players of Orencia
Table 7. Key Players of Actemra
Table 8. Key Players of Simponi
Table 9. Key Players of Cimzia
Table 10. Global Arthritis Monoclonal Antibodies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 11. Global Arthritis Monoclonal Antibodies Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 12. Global Arthritis Monoclonal Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Arthritis Monoclonal Antibodies Market Share by Region (2018-2023)
Table 14. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 15. Global Arthritis Monoclonal Antibodies Market Share by Region (2024-2033)
Table 16. Arthritis Monoclonal Antibodies Market Trends
Table 17. Arthritis Monoclonal Antibodies Market Drivers
Table 18. Arthritis Monoclonal Antibodies Market Challenges
Table 19. Arthritis Monoclonal Antibodies Market Restraints
Table 20. Global Arthritis Monoclonal Antibodies Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Arthritis Monoclonal Antibodies Market Share by Players (2018-2023)
Table 22. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2022)
Table 23. Ranking of Global Top Arthritis Monoclonal Antibodies Companies by Revenue (US$ Million) in 2022
Table 24. Global 5 Largest Players Market Share by Arthritis Monoclonal Antibodies Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Arthritis Monoclonal Antibodies Product Solution and Service
Table 27. Date of Enter into Arthritis Monoclonal Antibodies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Arthritis Monoclonal Antibodies Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2018-2023)
Table 31. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 32. Global Arthritis Monoclonal Antibodies Revenue Market Share by Type (2024-2033)
Table 33. Global Arthritis Monoclonal Antibodies Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2018-2023)
Table 35. Global Arthritis Monoclonal Antibodies Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 36. Global Arthritis Monoclonal Antibodies Revenue Market Share by Application (2024-2033)
Table 37. North America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Arthritis Monoclonal Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Arthritis Monoclonal Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Europe Arthritis Monoclonal Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Arthritis Monoclonal Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 43. Asia-Pacific Arthritis Monoclonal Antibodies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 44. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Arthritis Monoclonal Antibodies Market Size by Region (2024-2033) & (US$ Million)
Table 46. Latin America Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Arthritis Monoclonal Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 49. Middle East & Africa Arthritis Monoclonal Antibodies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 50. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Arthritis Monoclonal Antibodies Market Size by Country (2024-2033) & (US$ Million)
Table 52. AbbVie Inc Company Detail
Table 53. AbbVie Inc Business Overview
Table 54. AbbVie Inc Arthritis Monoclonal Antibodies Product
Table 55. AbbVie Inc Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 56. AbbVie Inc Recent Development
Table 57. F. Hoffmann-La Roche Ltd Company Detail
Table 58. F. Hoffmann-La Roche Ltd Business Overview
Table 59. F. Hoffmann-La Roche Ltd Arthritis Monoclonal Antibodies Product
Table 60. F. Hoffmann-La Roche Ltd Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Arthritis Monoclonal Antibodies Product
Table 65. Novartis Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Johnson & Johnson(Janssen) Company Detail
Table 68. Johnson & Johnson(Janssen) Business Overview
Table 69. Johnson & Johnson(Janssen) Arthritis Monoclonal Antibodies Product
Table 70. Johnson & Johnson(Janssen) Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 71. Johnson & Johnson(Janssen) Recent Development
Table 72. Pfizer Inc Company Detail
Table 73. Pfizer Inc Business Overview
Table 74. Pfizer Inc Arthritis Monoclonal Antibodies Product
Table 75. Pfizer Inc Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 76. Pfizer Inc Recent Development
Table 77. Mylan Company Detail
Table 78. Mylan Business Overview
Table 79. Mylan Arthritis Monoclonal Antibodies Product
Table 80. Mylan Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 81. Mylan Recent Development
Table 82. Genentech Company Detail
Table 83. Genentech Business Overview
Table 84. Genentech Arthritis Monoclonal Antibodies Product
Table 85. Genentech Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 86. Genentech Recent Development
Table 87. GSK Company Detail
Table 88. GSK Business Overview
Table 89. GSK Arthritis Monoclonal Antibodies Product
Table 90. GSK Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 91. GSK Recent Development
Table 92. AstraZeneca PLC Company Detail
Table 93. AstraZeneca PLC Business Overview
Table 94. AstraZeneca PLC Arthritis Monoclonal Antibodies Product
Table 95. AstraZeneca PLC Revenue in Arthritis Monoclonal Antibodies Business (2018-2023) & (US$ Million)
Table 96. AstraZeneca PLC Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Arthritis Monoclonal Antibodies Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Arthritis Monoclonal Antibodies Market Share by Type: 2022 VS 2033
Figure 3. Remicade Features
Figure 4. Humira Features
Figure 5. Enbrel Features
Figure 6. Rituxan Features
Figure 7. Orencia Features
Figure 8. Actemra Features
Figure 9. Simponi Features
Figure 10. Cimzia Features
Figure 11. Global Arthritis Monoclonal Antibodies Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 12. Global Arthritis Monoclonal Antibodies Market Share by Application: 2022 VS 2033
Figure 13. Rheumatoid Arthritis Case Studies
Figure 14. Osteoarthritis Case Studies
Figure 15. Psoriatic Arthritis Case Studies
Figure 16. Ankylosing Spondylitis Case Studies
Figure 17. Fibromyalgia Case Studies
Figure 18. Others Case Studies
Figure 19. Arthritis Monoclonal Antibodies Report Years Considered
Figure 20. Global Arthritis Monoclonal Antibodies Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 21. Global Arthritis Monoclonal Antibodies Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 22. Global Arthritis Monoclonal Antibodies Market Share by Region: 2022 VS 2033
Figure 23. Global Arthritis Monoclonal Antibodies Market Share by Players in 2022
Figure 24. Global Top Arthritis Monoclonal Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arthritis Monoclonal Antibodies as of 2022)
Figure 25. The Top 10 and 5 Players Market Share by Arthritis Monoclonal Antibodies Revenue in 2022
Figure 26. North America Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. North America Arthritis Monoclonal Antibodies Market Share by Country (2018-2033)
Figure 28. United States Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Canada Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Europe Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Europe Arthritis Monoclonal Antibodies Market Share by Country (2018-2033)
Figure 32. Germany Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. France Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. U.K. Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Italy Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Russia Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Nordic Countries Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Asia-Pacific Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Asia-Pacific Arthritis Monoclonal Antibodies Market Share by Region (2018-2033)
Figure 40. China Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Japan Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Southeast Asia Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. India Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Australia Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Latin America Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Latin America Arthritis Monoclonal Antibodies Market Share by Country (2018-2033)
Figure 48. Mexico Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Brazil Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East & Africa Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 51. Middle East & Africa Arthritis Monoclonal Antibodies Market Share by Country (2018-2033)
Figure 52. Turkey Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Saudi Arabia Arthritis Monoclonal Antibodies Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. AbbVie Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 55. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 56. Novartis Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 57. Johnson & Johnson(Janssen) Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 58. Pfizer Inc Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 59. Mylan Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 60. Genentech Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 61. GSK Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 62. AstraZeneca PLC Revenue Growth Rate in Arthritis Monoclonal Antibodies Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed